Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PEPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PEPG

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

PepGen Ltd

PEPG
Current price
1.25 USD +0.08 USD (+6.84%)
Last closed 1.16 USD
ISIN US7133171055
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 39 919 500 USD
Yield for 12 month -92.77 %
1Y
3Y
5Y
10Y
15Y
PEPG
21.11.2021 - 28.11.2021

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts. Address: 321 Harrison Avenue, Boston, MA, United States, 02118

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.00 USD

P/E Ratio

Dividend Yield

Financials PEPG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PEPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-1 184 000 USD

Current Quarter

Last Quarter

EBITDA -107 745 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -40.84 %
PEG Ratio
Return On Equity TTM -75.45 %
Wall Street Target Price 8.00 USD
Revenue TTM
Book Value 2.81 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.14 USD
Diluted Eps TTM -3.14 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation PEPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.11
Price Book MRQ 0.43

Technical Indicators PEPG

For 52 Weeks

0.88 USD 19.30 USD
50 Day MA 1.45 USD
Shares Short Prior Month 1 929 384
200 Day MA 3.56 USD
Short Ratio 10.26
Shares Short 1 803 461
Short Percent 10.45 %